Thanks to its dedicated volunteers, U.S. Pain Foundation’s 2019 Pain Awareness Month campaign, #LetsTalkAboutPain, was the most robust yet. All of the month’s activities—from educational events to the daily social media challenge—were possible through the generosity of Thrive Tape, makers of a far-infrared kinesiology tape.
“We chose the theme because we believe that speaking up about personal experiences is the first step to creating awareness and change,” says Interim CEO Nicole Hemmenway. “We are incredibly grateful to our supportive, passionate community for bringing pain to the forefront throughout September, and to Thrive Tape for providing the funding to support these efforts.”
The final online event in our Pain Awareness Month series will explore the ways in which patient advocacy–at both the state and federal levels–centers on sharing your personal pain story. The event will take place Wednesday, Sept. 25, from 11:30 AM – 12:30 pm EST.
U.S. Pain Interim CEO Nicole Hemmenway will moderate a panel discussion with Cindy Steinberg, U.S. Pain National Director of Policy and Advocacy, Shaina Smith, U.S. Pain Director of State Advocacy and Alliance Development, and special guest Rhode Island State Rep. Patricia Serpa.
Too often, due to broad misconceptions and a lack of understanding about pain, pain warriors are afraid or ashamed to speak up about their stories.
But the only way we can create change is if we start talking–to loved ones, coworkers, neighbors, clinicians, and even policymakers.
That’s why our theme for Pain Awareness Month 2019, which begins September 1, is “Let’s Talk about Pain.” We’ll be hosting numerous events, campaigns, and activities that center around this idea. In order to truly get the word out, though, we need your help.
By Jorie Logan-Morris and Jeannette Rotondi
Every year in February, advocates for migraine and headache disease come together in Washington, D.C., for an event known as Headache on the Hill (HOH). HOH is organized by the Alliance for Headache Disorders Advocacy (AHDA) and has been running now for 12 years.
During HOH, advocates of all kinds — migraine and headache patients, caregivers, doctors and specialists, and more — work together to lobby and meet with Congress, presenting important legislation and “asks” related to migraine and headache disease in hopes that lawmakers will support our requests. This in turn helps bring more national awareness to migraine and headache disease and ultimately further supports the millions who suffer all across the country.
U.S. Pain’s Director of State Advocacy and Alliance Development Shaina Smith was among the speakers at the Biotechnology Innovation Organization’s (BIO) Patient and Health Advocacy Summit held Oct. 25 and 26 in Washington, D.C. The annual event brings together patient advocacy organizations, academia, regulators, biotechnology industry, and other stakeholders to discuss timely policy issues and share best practices. This year, attendees were treated to a surprise appearance from U.S. Secretary of Health and Human Services Alex Azar.
Volunteers who have signed up to join the Advocacy Network joined an invitation-only training webinar to learn about an issue impacting families and individuals across the country: surprise bills.
The presentation was the first of a series of advocacy training webinars scheduled for the upcoming year, according to Director of State Advocacy and Alliance Development, Shaina Smith. “We’re really trying to develop and offer resources that will improve the lives of people with chronic illness through education,” Smith explains. “The more we learn as a community, the greater chance we will have at successfully moving patient-friendly policies forward.”
Policymakers across both aisles have had mixed viewpoints when it comes to cultivating cannabis, not in the literal sense, but as it relates to bills that would permit individuals to access medical cannabis. Several states, however, are expanding or considering expanding their medical cannabis programs, including Illinois, New York, and New Jersey. In addition, some federal institutions have taken steps to improve access: the Food and Drug Administration (FDA), the Drug Enforcement Administration (DEA), and Congress.
Now, more than ever, it is important for people with pain need to support each other, uniting to bring awareness and understanding. Throughout September, U.S. Pain will be providing numerous opportunities for you to join us in making a positive change for pain warriors. Take a look at some of U.S. Pain’s upcoming activities and events so that you can help honor Pain Awareness Month. It’s never too late to get involved, and there’s something for everyone, no matter what your abilities or interests.
California has long been a harbinger of medical cannabis access. In 1996, it approved medical cannabis for patients with a physician’s recommendation, and in 2016, it legalized marijuana for all residents. Continuing to lead the way on this therapeutic treatment option, lawmakers are considering Assembly Bill 1996, which would establish a research program on the medical use of cannabis. It would be the first of its kind in the country.